Aytu BioScience Announces Results from a National Cancer Institute Evaluation of the Company's Licensed COVID-19 IgG/IgM Rapid Test

Stock Information for Aytu BioPharma Inc.

Loading

Please wait while we load your information from QuoteMedia.